What Can I Compare With The Pep Nation Lab Comparison Tool?

Any research-grade compound in the library can be placed side by side - up to four at a time. The tool compares mechanism of action, molecular target, evidence tier, molecular weight, amino acid sequence, reported half-life, and what each compound has been studied for, all drawn from referenced monographs.

What Does The Evidence Tier Mean?

The evidence tier reflects how extensively a compound has been studied in the referenced literature, from early preclinical signals through to compounds with human clinical data. It is a research-quality signal only, never a safety or efficacy endorsement.

How Are "X vs Y" Comparison Pages Built?

Each comparison page is generated from the same referenced compound database - a genuine side-by-side of mechanism, identity, pharmacokinetics, and evidence, plus data-derived key differences. They are curated, not auto-generated thin pages.

Is Any Of This Medical Or Dosing Advice?

No. Every comparison is for in vitro laboratory research use only. Nothing here is medical advice, a treatment recommendation, or dosing guidance, and no product is for human or animal consumption.

Compare Compounds

Select Up To Four Compounds To Review Their Evidence, Targets, And Handling Side By Side.
For Laboratory Research Only

2/4

Diff ModeHide Identical

ARA-290B-83

BPC-157A+98

Top Pick: BPC-157Tap to see full verdict & analysis

ARA-290

0/100

Grade B-

Leads in evidence strength

Evidence

Safety

Science

Coverage

Handling

Depth

Unique: Cognitive

BPC-157

0/100

Grade A+

Leads in safety profile

Evidence

Safety

Science

Coverage

Handling

Depth

Unique: Tissue Repair, Gut Health & GI Repair

Research Profile Radar - hover axes for details

ARA-290

BPC-157

Zoom100%

Attribute	ARA-290 B-	BPC-157 A+
Research Summary	ARA-290 acts like a tiny firefighter for your nerves. When nerves are damaged or hurting, it puts out the fire (inflammation) and helps the broken nerve cables heal themselves.	Think of BPC-157 as the ultimate "Fix-It" mechanic for your body. Whether it is a torn muscle, a sore joint, or a damaged stomach, it rushes to the site and speeds up the healing process incredibly fast.
Studied For	Small-fiber neuropathy (sarcoidosis, diabetes)Neuropathic pain researchTissue-injury repairDiabetic neuropathy modelsSarcoidosis-related neuropathyCorneal nerve fiber regenerationImmune modulationAnti-inflammatorySepsis modelsCardiac ischemia protectionRenal protectionObesity metabolic improvementBeta-cell protection in diabetesWound healing accelerationneuropathynerve painanti-inflammatorytissue repairsmall fiber neuropathysarcoidosisdiabetic neuropathy	GI mucosal healingTendon / ligament repairNerve repairAnti-inflammatoryGut health and integrityLeaky gut researchIBD / Crohn's disease modelsUlcerative colitis modelsGastric ulcer healingIntestinal anastomosis healingWound healing accelerationMuscle tear recoverySports injury recoveryJoint inflammation reductionBone healingCartilage repairNeurological recoverySpinal cord injury modelsPeripheral nerve regenerationAngiogenesis promotionBlood pressure regulationNitric oxide pathwayGrowth hormone receptor upregulationCytoprotectionSystemic healingNSAID-induced gastric damage reversalAlcohol-induced gut damage reversalPost-surgical healingScar reductionAnti-ulcer researchjoint healinggut healingtendon repairulcer repairligament healingmuscle tear recoveryleaky gutinflammation reductionpain reliefsoft tissue repair
Research Areas	Healing & RecoveryImmunePain & InflammationCognitive	Healing & RecoveryTissue RepairGut Health & GI RepairPain & InflammationJoint & Bone SupportImmune
Best Stacked With	ll-37thymosin-alpha-1bpc-157bac-water	tb-500ghk-cukpvll-37bac-water
Overview
Category	Immunity & Wellness	Healing & Recovery
Compound Class	Non-hematopoietic EPO-derived 11-amino acid cyclic peptide; innate repair receptor agonist	Synthetic pentadecapeptide derived from human gastric juice protein BPC
Molecular Target	Innate repair receptor (IRR = EPO-R + CD131 beta-common heterodimer); tissue-protective signaling without erythropoiesis; anti-apoptotic and anti-inflammatory	NO-synthase, VEGF, FAK/paxillin, EGF receptor, growth hormone receptor; promotes angiogenesis, collagen synthesis, and cytoprotection
Aliases / AKA	CibinetideARA290ARA-290 peptideNon-hematopoietic EPO peptideTissue-protective peptide EPOInnate repair receptor agonist	Body Protection Compound 157BPC157BPC 157BPC-157Pentadecapeptide BPC 157Stable Gastric Pentadecapeptide
Parent Compound	Erythropoietin helix-B domain	Gastric juice BPC protein fragment
Molecular Weight	1257.4 Da	1419.5 Da
Amino Acid Sequence	`QEQLERALNSS`	`Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val`
CAS Number	1208243-50-8	137525-51-0
Year Discovered	Not Listed	Not Listed
Pro-Angiogenic	No	Yes - Promotes New Vessel Growth
GLP-1 Class	No	No
Purity	Not Listed	Not Listed
Identity
Evidence Tier
Risk Level
PubMed Citations	305 Good	224 Good
Clinical Trials	22 Active	22 Active
Regulatory Status	Investigational; FDA orphan designation; not marketed.	Not FDA-approved; under FDA compounding-safety review (503A bulk-substances evaluation); research chemical.
Evidence & Regulatory
Half-Life	~2 minutes	~30 minutes
Typical Frequency	Not Listed	Not Listed
Administration Route	Injection Only	Injection Only
Mechanism / PK	Not Listed	Not Listed
Reported Findings	Multiple Phase 2 trials, including a controlled sarcoidosis small-fiber neuropathy study, reported pain relief and improved corneal nerve-fiber measures. Early-phase but rigorously controlled.	Evidence is overwhelmingly rodent and in vitro: accelerated healing, angiogenesis, and protection against NSAID gastrointestinal damage. Human evidence is very limited; injectable musculoskeletal claims are not established in humans.
Side Effects Noted	Reported well tolerated; designed to avoid the blood-thickening effects of erythropoietin.	Rodent toxicology is benign but human adverse-event data are essentially absent. FDA flags immunogenicity, unknown long-term effects, and a theoretical pro-angiogenic tumor-vascularization risk.
Warnings	Investigational with FDA orphan designation; no completed Phase 3. Research use only.	Not approved; flagged by the FDA under its 503A bulk-substances compounding-safety review. The pro-angiogenic mechanism is a theoretical concern in any malignancy. Research use only.
Pharmacology
Form	lyophilized	lyophilized
Diluent	sterile or bacteriostatic water	bacteriostatic or sterile water; swirl, do not shake
Storage Temp	frozen/refrigerated, dark	2-8C; -20C long-term, dark
Light Sensitive	Yes	Yes
Freeze / Thaw	avoid	avoid
Handling Notes	Subcutaneous and IV routes used in trials.	Reported stable in gastric juice; arginate salt aids stability.
Reconstituted Shelf Life	28 Days Refrigerated	28 Days Refrigerated
Handling & Storage

Popular Research Comparisons

BPC-157 vs TB-500 / Thymosin Beta-4
The two most-studied research peptides for tissue repair and recovery.
Semaglutide vs Tirzepatide
Single GLP-1 versus dual GLP-1/GIP incretin agonists in metabolic research.
Tirzepatide vs Retatrutide
Dual versus triple incretin receptor agonists in weight-research models.
Semaglutide vs Retatrutide
A GLP-1 agonist versus a triple-agonist incretin in metabolic research.
CJC-1295 With DAC vs Ipamorelin
A GHRH analog versus a selective ghrelin-receptor secretagogue.
Ipamorelin vs Sermorelin
A ghrelin-receptor secretagogue versus a GHRH analog for growth-hormone research.
Sermorelin vs Tesamorelin
Two GHRH analogs studied on the growth-hormone axis.
GHRP-2 vs GHRP-6
The two first-generation growth-hormone releasing peptides.
Cagrilintide vs Semaglutide
An amylin analog versus a GLP-1 agonist in metabolic research.
MOTS-c vs AOD9604
A mitochondrial-derived peptide versus an HGH fragment in metabolic research.
PT-141 vs Kisspeptin-10
Melanocortin versus kisspeptin pathways in reproductive research.
Epithalon vs NAD+
A telomerase-pathway peptide versus NAD+ metabolism in longevity research.
Hexarelin vs Ipamorelin
A potent versus a highly selective ghrelin-receptor secretagogue.
CJC-1295 With DAC vs Tesamorelin
Two GHRH analogs with contrasting half-life profiles.
IGF-1 LR3 vs Ipamorelin
A direct IGF-1 analog versus a growth-hormone secretagogue.
CJC-1295 With DAC vs CJC-1295 Without DAC
The DAC versus non-DAC forms of the CJC-1295 GHRH analog.
Selank vs Semax
Two Russian-developed nootropic and anxiolytic research peptides.
SS-31 vs MOTS-c
Two mitochondrial-targeted peptides in cellular-energy research.
Thymosin Alpha-1 vs LL-37
Two immune-modulating research peptides with distinct mechanisms.
AOD9604 vs HGH Fragment 176-191
Two HGH-fragment analogs studied for fat-metabolism research.
Retatrutide vs Survodutide
Next-generation multi-receptor incretin agonists in metabolic research.
BPC-157 vs GHK-Cu
Two leading tissue-repair peptides with distinct healing mechanisms.
TB-500 / Thymosin Beta-4 vs GHK-Cu
A systemic repair peptide versus a copper peptide for tissue and skin research.
Tesamorelin vs Ipamorelin
A GHRH analog versus a selective ghrelin-receptor secretagogue on the GH axis.
Tirzepatide vs Cagrilintide
A dual incretin agonist versus an amylin analog in metabolic research.
Retatrutide vs Cagrilintide
A triple incretin agonist versus an amylin analog in weight research.
MOTS-c vs 5-Amino-1MQ
Two metabolic research compounds targeting mitochondrial and NNMT pathways.
NAD+ vs MOTS-c
NAD+ metabolism versus a mitochondrial-derived peptide in longevity research.
GHK-Cu vs AHK-Cu
Two copper research peptides studied for skin and hair.
CJC-1295 With DAC vs Sermorelin
A long-acting versus a short-acting GHRH analog.
Ipamorelin vs GHRP-6
A selective versus a first-generation ghrelin-receptor secretagogue.
Semaglutide vs The Appetite Crusher Stack
A GLP-1 agonist versus a GLP-1/amylin combination in metabolic research.
BPC-157 vs KPV
Two peptides studied for gut and mucosal repair.
PT-141 vs Oxytocin
Melanocortin versus oxytocin pathways in intimacy and libido research.
Thymosin Alpha-1 vs Thymalin
Two thymic immune-modulating research peptides.
Selank vs DSIP
An anxiolytic nootropic versus a sleep-associated research peptide.
IGF-1 LR3 vs Follistatin
Direct IGF-1 signaling versus myostatin inhibition in muscle research.
SS-31 vs NAD+
A mitochondrial-targeted peptide versus NAD+ in cellular-energy research.
BPC-157 vs The Wolverine Stack
Single BPC-157 versus the combined BPC-157 and TB-500 blend in recovery research.
Ipamorelin vs The Fountain of Youth Stack
Ipamorelin alone versus the CJC-1295 and ipamorelin blend on the growth-hormone axis.
Semax vs Cerebrolysin
A synthetic ACTH-fragment nootropic versus a neurotrophic peptide preparation in cognitive research.
Melatonin vs DSIP
Two sleep-research compounds with distinct mechanisms.
GHK-Cu vs SNAP-8
A copper tripeptide versus an acetyl hexapeptide in cosmetic and skin research.
FOXO4-DRI vs Epithalon
A senolytic peptide versus a telomerase-pathway peptide in longevity research.
AICAR vs 5-Amino-1MQ
Two metabolic research compounds targeting the AMPK and NNMT pathways.
Tesamorelin vs HGH Fragment 176-191
A GHRH analog versus an HGH fragment in fat-metabolism research.
MOTS-c vs AICAR
Two AMPK-associated mitochondrial and metabolic research compounds.
ARA-290 vs BPC-157
Two peptides studied for tissue protection and repair.
VIP vs KPV
Two peptides studied for immune and inflammatory modulation.
Pinealon vs Epithalon
Two peptide bioregulators studied in longevity and neuro research.
Survodutide vs Tirzepatide
A glucagon/GLP-1 dual agonist versus a GIP/GLP-1 dual agonist in metabolic research.

Accessing Library

Compare Compounds

Compare Research Peptides Side By Side

Popular Research Comparisons

Compounds You Can Compare

Comparison Tool FAQ